Mohammed O Gbadamosi

3PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 09, 2025
Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy.

Mohammed O Gbadamosi, Elizabeth Molchan, Mariana S Makarem

|May 13, 2025
A genome-wide association study using HapMap cell lines reveals modulators of cellular response to cyclophosphamide.

Mohammed O Gbadamosi, Neha Bhise, Taraswi Mitra Ghosh

|Jan 10, 2024
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology Group.

Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi

Pageof 1